Starling Oncology, Inc. SEC filings DFPH

Starling Oncology, Inc. has 544 filings in SEC EDGAR's recent list, going back to Jan 14, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Starling Oncology, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Officer or director change
Sep 2, 2026 Sep 1, 2026
8-K Current report
Material agreement, New debt
Aug 21, 2026 Aug 20, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Aug 3, 2026 Jul 28, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Jul 7, 2026 Jul 1, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 17, 2026
8-K Current report May 22, 2026 May 20, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
8-K Current report
Regulation FD disclosure
Mar 13, 2026 Mar 13, 2026
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 23, 2026 Feb 23, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 7, 2026 Jan 2, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 1, 2025 Nov 26, 2025
8-K Current report
Regulation FD disclosure
Nov 14, 2025 Nov 14, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
8-K Current report
Regulation FD disclosure
Nov 6, 2025 Nov 3, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 13, 2025 Aug 8, 2025
8-K Current report
Regulation FD disclosure
May 19, 2025 May 19, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
8-K Current report
Shareholder vote results
May 8, 2025 May 7, 2025
8-K Current report
Officer or director change
May 7, 2025 May 2, 2025
8-K Current report
Other events
Apr 11, 2025 Apr 9, 2025
8-K Current report
Material agreement, Unregistered share sale
Mar 27, 2025 Mar 26, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Mar 25, 2025 Mar 24, 2025
8-K Current report
Regulation FD disclosure
Mar 24, 2025 Mar 24, 2025
8-K Current report
Results of operations
Mar 24, 2025 Mar 24, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Feb 26, 2025 Feb 26, 2025
8-K Current report
Listing notice
Dec 19, 2024 Dec 19, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
8-K Current report
Officer or director change
Nov 12, 2024 Nov 8, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 23, 2024 Sep 19, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Listing notice
Jun 21, 2024 Jun 20, 2024
8-K Current report
Shareholder vote results
Jun 13, 2024 Jun 13, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Apr 3, 2024 Apr 3, 2024
8-K Current report
Results of operations
Mar 27, 2024 Mar 27, 2024
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Other events
Sep 18, 2023 Sep 15, 2023
8-K Current report
Officer or director change
Sep 6, 2023 Sep 6, 2023
8-K Current report
Officer or director change
Sep 1, 2023 Sep 1, 2023
8-K Current report
Other events
Aug 30, 2023 Aug 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 10, 2023 Aug 10, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 8, 2023
8-K Current report
Shareholder vote results
Jun 20, 2023 Jun 15, 2023
8-K Current report
Other events
Jun 15, 2023 Jun 14, 2023
8-K/A Amended current report
Officer or director change, Regulation FD disclosure
Jun 14, 2023 Jun 8, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 12, 2023 Jun 11, 2023
8-K Current report
Officer or director change
May 22, 2023 May 18, 2023
8-K Current report
Results of operations
May 10, 2023 May 10, 2023
8-K Current report
Listing notice
Apr 27, 2023 Apr 25, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 27, 2023 Mar 27, 2023
8-K/A Amended current report
Results of operations
Mar 17, 2023 Mar 9, 2023
8-K Current report
Results of operations
Mar 9, 2023 Mar 9, 2023
8-K Current report
Officer or director change
Dec 1, 2022 Nov 27, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 15, 2022 Nov 15, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 22, 2022 Sep 21, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 16, 2022 Aug 16, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Aug 10, 2022 Aug 9, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Shareholder vote results
Jul 15, 2022 Jul 14, 2022
8-K Current report
Other events
May 12, 2022 May 12, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 11, 2022 May 11, 2022
8-K Current report
Officer or director change
May 5, 2022 Apr 29, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 4, 2022 Apr 1, 2022
8-K/A Amended current report Mar 18, 2022 Mar 11, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Mar 11, 2022 Mar 11, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Mar 10, 2022 Mar 10, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 7, 2022 Mar 2, 2022
8-K Current report
Restatement
Dec 9, 2021 Dec 8, 2021
8-K/A Amended current report
Material agreement, Acquisition or sale of assets
Nov 22, 2021 Nov 12, 2021
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
Nov 18, 2021 Nov 12, 2021
8-K Current report
Other events
Oct 22, 2021 Oct 22, 2021
8-K Current report
Regulation FD disclosure
Oct 12, 2021 Oct 12, 2021
8-K Current report
Material agreement, Unregistered share sale
Jun 29, 2021 Jun 28, 2021
8-K Current report
Regulation FD disclosure
Jun 28, 2021 Jun 28, 2021
8-K Current report
Restatement
May 18, 2021 May 14, 2021
8-K Current report
Other events
Apr 28, 2020 Apr 28, 2020
8-K Current report
Other events
Mar 19, 2020 Mar 13, 2020
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
Mar 13, 2020 Mar 10, 2020

Showing 84 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
STLN (Nasdaq), DFPH (OTC), STLNW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cerritos, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1799191
Former names
Oncology Institute, Inc. (until Aug 3, 2026); DFP HEALTHCARE ACQUISITIONS CORP. (until Nov 12, 2021)

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.